121 related articles for article (PubMed ID: 7966159)
1. Chemical and biological evaluation of hydrolysis products of cyclophosphamide.
Gilard V; Martino R; Malet-Martino MC; Kutscher B; Müller A; Niemeyer U; Pohl J; Polymeropoulos EE
J Med Chem; 1994 Nov; 37(23):3986-93. PubMed ID: 7966159
[TBL] [Abstract][Full Text] [Related]
2. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
[TBL] [Abstract][Full Text] [Related]
3. Identification of new aqueous chemical degradation products of isophosphoramide mustard.
Breil S; Martino R; Gilard V; Malet-Martino M; Niemeyer U
J Pharm Biomed Anal; 2001 Jun; 25(3-4):669-78. PubMed ID: 11377048
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide.
Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor properties of activated cyclophosphamide analogues.
Borch RF; Canute GW
J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
[TBL] [Abstract][Full Text] [Related]
6. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
[TBL] [Abstract][Full Text] [Related]
7. Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
al-Razzak LA; Benedetti AE; Waugh WN; Stella VJ
Pharm Res; 1990 May; 7(5):452-60. PubMed ID: 2367313
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of monomeric and polymeric cyclophosphamide derivatives compared with in vitro hydrolysis.
Hirano T; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Jul; 40(7):2263-7. PubMed ID: 7388792
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data.
Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
Denora N; Potts BC; Stella VJ
J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
[TBL] [Abstract][Full Text] [Related]
11. Adriamycin analogues. rationale, synthesis, and preliminary antitumor evaluation of highly active DNA-nonbinding N-(trifluoroacetyl)adriamycin 14-O-hemiester derivatives.
Israel M; Potti PG; Seshadri R
J Med Chem; 1985 Sep; 28(9):1223-8. PubMed ID: 3839851
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies.
Sonawat HM; Leibfritz D; Engel J; Hilgard P
Biochim Biophys Acta; 1990 Apr; 1052(1):36-41. PubMed ID: 2322593
[TBL] [Abstract][Full Text] [Related]
13. Hydrolytic pathway of 5-fluorouracil in aqueous solutions for clinical use.
Legay R; Massou S; Azéma J; Martino R; Malet-Martino M
J Pharm Biomed Anal; 2014 Sep; 98():446-62. PubMed ID: 25038499
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
Maki PA; Sladek NE
Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
[TBL] [Abstract][Full Text] [Related]
15. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
Xiang TX; Niemi R; Bummer P; Anderson BD
J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the hydrolysis of guanosine 5'-phospho-2-methylimidazolide.
Kanavarioti A
Orig Life Evol Biosph; 1986; 17(1):85-103. PubMed ID: 11536569
[TBL] [Abstract][Full Text] [Related]
17. Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.
Sladek NE; Low JE; Landkamer GJ
Cancer Res; 1985 Feb; 45(2):625-9. PubMed ID: 3967238
[TBL] [Abstract][Full Text] [Related]
18. Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
Kwon CH; Maddison K; LoCastro L; Borch RF
Cancer Res; 1987 Mar; 47(6):1505-8. PubMed ID: 3815352
[TBL] [Abstract][Full Text] [Related]
19. 4-(beta-Arylvinyl)-3-(beta-arylvinylketo)-1-ethyl-4-piperidinols and related compounds: a novel class of cytotoxic and anticancer agents.
Dimmock JR; Vashishtha SC; Quail JW; Pugazhenthi U; Zimpel Z; Sudom AM; Allen TM; Kao GY; Balzarini J; De Clercq E
J Med Chem; 1998 Oct; 41(21):4012-20. PubMed ID: 9767639
[TBL] [Abstract][Full Text] [Related]
20. Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide.
Niemeyer U; Engel J; Scheffler G; Molge K; Sauerbier D; Weigert W
Invest New Drugs; 1984; 2(2):133-9. PubMed ID: 6469506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
